Found 5 matching trials
Study to Test the Long Term Safety and Efficacy of the Beta-3 Agonist Mirabegron (YM178) in Patients With Symptoms of Overactive Bladder PHASE3 The study is intended to test the safety, tolerability, efficacy of two dos...
Show More Location
Multiple Locations
Learn More & Join Trial
Low Dose Tadalafil for Treatment of Female OAB Syndrome: Short Term Follow up. PHASE1 Evaluation of use of low dose tadalafil 5 mg daily for treatment of female ...
Show More Learn More & Join Trial
A Study of the Pharmacokinetics and Pharmacodynamics of Vibegron (MK-4618) in Women With Overactive Bladder (MK-4618-004) PHASE1 The study is designed to investigate the effects of the investigational dru...
Show More Location
Multiple Locations
Learn More & Join Trial
A Study to Evaluate Tolerability and Participants Preference Between Mirabegron and Tolterodine Extended Release (ER) in Participants With Overactive Bladder (OAB) PHASE4 The purpose of this study was to assess tolerability of mirabegron compared...
Show More Location
Site US10002 Urology Centers of Alabama
Learn More & Join Trial
A Study of the Efficacy and Safety of Vibegron (MK-4618) in Participants With Overactive Bladder (OAB) (MK-4618-008) PHASE2 This is a 2-part study to assess if vibegron (MK-4618) reduces the number o...
Show More Location
Multiple Locations
Learn More & Join Trial